Re: Zenith AGM

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith AGM

in response to

Zenith AGM

Albertaclipper

posted on Aug 22, 2019 07:18PM

Thanks AlbertaClipper. I re-posted as a press release. For future reference, when you post a new message, you can toggle the button to "Press Release" from the default "Message" and it will subsequently show up in the Recent Updates section of the Agoracom Zenith homepage.